Topic: Eli Lilly

The U.S. Food and Drug Administration on Monday granted approval to Olumiant, an alopecia treatment developed by Eli Lilly that produced hair regrowth in trials.

A newly approved drug for Type 2 diabetes may be a game-changer for treating obesity, too.

Anybody in the United States who watches television knows about the skin condition psoriasis -- and the commercials they see may be contributing to a rise in psoriasis diagnoses, experts say.

The Food and Drug Administration on Friday granted emergency use authorization for a new monoclonal antibody drug to treat COVID-19.

A new lung cancer drug that has only been tested in China was soundly rejected by an advisory panel to the U.S. Food and Drug Administration on Thursday.

The Food and Drug Administration on Monday halted use of monoclonal antibody treatments from Regeneron and Eli Lilly, stating they are ineffective against the Omicron COVID-19 variant.

As doctors around the world come up against severe cases of COVID-19, some positive news has emerged: New research shows the rheumatoid arthritis drug baricitinib may help reduce hospitalized patients' risk of death.

South Korean pharmaceutical company Celltrion announced that its antibody COVID-19 drug Rekirona is safe and effective after global clinical trials.

The S&P 500 hit a record closing high of 4,239.18 on Thursday as investors largely shrugged off a Bureau of Labor Statistics report detailing rising inflation.

Eli Lilly said Friday it's asked federal regulators to revoke emergency use authorization for lone use of its COVID-19 antibody bamlanivimab, as it develops a combination therapy with the drug it says is more effective.